Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of oral live attenuated human rotavirus liquid vaccine in healthy infants in the Philippines
2015-001544-11Phase 2
- Sponsor
- GSK
- Start
- Jun 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in rotaviral diarrhea comparing HRV liquid vaccine with Placebo (2 arms). Primary endpoint: Anti-rotavirus IgA antibody seroconversion.
02
Drugs
rotavirus vaccine, live, oral
03
Conditions
rotaviral diarrhea
Beyond the preview
Go deeper on 2015-001544-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001544-11.